Latham & Watkins Advises Omada Health on Growth Financing

Latham & Watkins advised Omada Health, Inc., a virtual-first healthcare provider that implements clinically-validated behavior change protocols for individuals living with prediabetes, diabetes, hypertension, and musculoskeletal issues, in a financing consisting of a US$60 million term loan and US$20 million in asset-based revolving credit facilities. MidCap Financial acted as agent and lender in the financing, which closed on June 2, 2023.

Latham & Watkins LLP advised Omada Health in the transaction with a transactional team led by Bay Area/New York partner Haim Zaltzman, Bay Area partner Kathleen Wells, with associates Benjamin Gelfand and Rychelle Andersen. Advice was also provided on healthcare matters by Washington, D.C. counsel Nicole Liffrig-Molife, with associate Margaret Rote; and on tax matters by Los Angeles partner Eric Cho, with Washington, D.C. associate Abigail Friedman.